Skip to main content

Vitamin B12 Supplementation in Urinary Diversion

Vitamin B12 deficiency is the best-characterized long-term nutritional complication of urinary reconstruction with ileal segments — a silent, slow-onset, and partly irreversible problem that the reconstructive urologist should plan to monitor for the rest of the patient's life. Intrinsic-factor-dependent B12 absorption occurs in the terminal ileum; a small proportion of a high oral dose can also be absorbed passively elsewhere, and the body's 2–5 mg hepatic store is large enough that clinical deficiency may not declare itself for 3–5 years after surgery.[5][6][7] By then, neurological damage — subacute combined degeneration, peripheral neuropathy, cognitive change — may not fully reverse with repletion, making surveillance and empirical supplementation the point of the whole exercise.[6][7]

A smaller but growing body of evidence links B12 status to male reproductive health (testosterone, sperm quality) and to vasculogenic erectile function via the homocysteine axis.[3][4][18][19] This article covers both — the diversion-surveillance story first, then the andrology adjunct.

For adjacent long-term diversion topics see Mucus management and Urinary acidifiers & alkalinizers.

Why Ileal Diversion Causes B12 Deficiency​

Anatomic factorEffect on B12 absorption
Resection > 30 cm of terminal ileumIncreased risk of deficiency[5]
Loss of ~ 50 cm of terminal ileumHistorical cohort, not a universal threshold: reduced absorption in 20/25 Kock pouch patients versus 0/29 ileal-neobladder patients; both groups included patients with low serum B12[8]
Use of ileocecal segment (Indiana, Mainz)Potential loss of distal-ileal absorptive function; assess the actual bowel segment and remaining anatomy[9]
Colonic neobladder (ascending, sigmoid)Avoids direct loss of ileal absorption if ileum is preserved; other causes of B12 deficiency remain possible[10]

The length/segment rule is the clinical bottom line: the more terminal ileum taken and the more ileocecal region included, the more aggressively you should plan B12 surveillance. This nutritional consideration alone does not determine diversion choice.[10]

Historical Series by Diversion Type​

These small cohorts used different tests and follow-up durations. Zero events in one cohort is not proof of zero risk; Schilling results measure absorption, not the same outcome as a low serum level.

DiversionIleal length usedLow serum B12Schilling-confirmed malabsorptionTypical latency
Ileal conduit15–20 cm15–25%[1][2]Variable5–15 yr
Ileal neobladder (Studer)40–60 cm13.6%[10]Not routinely tested9 mo – 3 yr
Kock pouch~50 cm terminal ileum16%[8]80% (20/25)[8]Variable
Ileocolic neobladder (Mainz)Ileocecal segment16.6–25%[7][10]~13% confirmed5–6 yr
Indiana pouchIleocecal segmentVariable67% (4/6)[9]Variable
Colonic neobladder0 cm ileum0%[10]N/AN/A
Pediatric ileal enterocystoplasty15–25 cm13–28% low / low-normal[13][14]Not routine≥ 7 yr

Serum B12 alone underestimates the true burden. Sagalowsky & Frenkel 2002 — complete cobalamin profiles (serum B12 + MMA + homocysteine) in 41 diversion patients showed tissue deficiency prevalence significantly higher than serum B12 alone would suggest.[11]

Clinical Manifestations — What Not to Miss​

B12 deficiency produces two categories of damage with very different reversibility.[6]

Hematologic (typically reversible)

  • Megaloblastic anemia, macrocytosis, hypersegmented neutrophils, pancytopenia
  • No patient in the major urologic series developed frank megaloblastic anemia — this does not prove surveillance was the cause or that anemia is required for diagnosis[7][10][12]

Neurologic (potentially irreversible)

  • Subacute combined degeneration of the spinal cord (dorsal and lateral column demyelination)
  • Peripheral neuropathy — paresthesias, numbness, gait ataxia
  • Cognitive dysfunction, dementia, psychiatric change
  • One patient in Steiner et al.'s ileocolic neobladder series presented with neurologic symptoms at 53 months postoperatively — the only symptomatic case in that cohort and a cautionary tale about long latency[7]
  • Neurologic B12 deficiency can occur without anemia or macrocytosis — do not use a normal blood count to exclude it[6]

Other: glossitis, infertility, venous thromboembolism (including cerebral venous sinus thrombosis).[6]

Neurologic damage may not fully reverse with repletion. This — not anemia — is the reason annual surveillance is worth the effort.

Monitoring and Screening​

EAU recommends annual B12 measurement after cystectomy with bowel diversion. Continue surveillance rather than assuming preserved serum levels early after surgery eliminate later risk. In neurogenic bowel-segment reconstruction, AUA/SUFU recommends monitoring B12 over time when terminal ileum is used.[15][22]

  • Record the actual resected/bypassed ileal segment, baseline nutritional status and other causes such as dietary deficiency, gastric disease or medication use.
  • Use the laboratory's total/active-B12 thresholds; consider MMA for an indeterminate result with compatible symptoms. Interpret MMA with renal function because renal impairment can raise it independently. Homocysteine is less specific.[11][16][23]
  • Schilling testing is historical, not a routine contemporary diagnostic step. Do not wait for it before treating clinically significant deficiency.
  • Pediatric cohorts show rising risk with longer follow-up; plan monitoring with the pediatric reconstruction team and test earlier for symptoms, nutritional concerns or extensive ileal loss rather than treating year 5 as a prohibition on earlier testing.[13][14]
  • When neurologic or significant hematologic manifestations suggest deficiency, arrange prompt treatment and clinical follow-up; a low or borderline B12 value is not the only relevant outcome.[6][23]

Replacement: Choose the Route for the Cause and Severity​

Parenteral replacement is appropriate for clinically important malabsorption, neurologic disease or unreliable oral response/adherence. The loading and maintenance regimen depends on the selected cyanocobalamin/hydroxocobalamin product and local protocol; a monthly maintenance dose is not an adequate loading instruction for a symptomatic patient.[5][17][23]

High-dose oral therapy can work through passive absorption. The 2018 Cochrane review (3 trials, 153 participants) found low-certainty evidence for comparable short-term serum-level correction with oral and IM therapy, but the review did not provide usable evidence on clinical neurologic outcomes. This does not prove equivalent treatment of every malabsorptive or symptomatic patient.[24]

The OB12 trial (2020; 283 adults aged ≥65 years) found oral B12 1 mg daily for 8 weeks noninferior to IM therapy for serum normalization at 8 weeks. Oral treatment then fell to 1 mg weekly; noninferiority was not established at 52 weeks. This was not a urinary-diversion trial or a test of continuing oral 1 mg daily throughout maintenance.[25]

NICE's adult guideline recommends lifelong IM replacement after complete terminal ileal resection, and consideration of IM therapy for other malabsorption. If oral therapy is chosen for malabsorption, use at least 1 mg/day and assess response. A limited ileal diversion is not automatically equivalent to complete terminal ileal resection.[23]

Vanderbrink's pediatric ileocystoplasty cohort reported serum improvement with 250 µg/day oral therapy; that study is not a universal adult repletion dose or proof of pediatric neurologic efficacy.[14] Monitoring or empirical supplementation has been proposed after diversion; choose an individualized plan and continue follow-up rather than assuming a supplement eliminates deficiency risk.[11]

B12 and Male Reproductive / Sexual Health​

Erectile dysfunction​

  • Xu 2021 (n = 184) — ED patients had lower B12 levels (256 vs 337.5 pg/mL; p < 0.05)[4]
  • Chen 2019 (n = 1,381, China) — paradoxically found higher B12 in men with ED (718.5 vs 688.7 pg/mL; p = 0.015); higher B12 associated with mild ED (OR 1.62)[18] — the cross-sectional design cannot establish direction or mechanism
  • Proposed mechanism involves homocysteine — B12 deficiency raises homocysteine, which drives endothelial dysfunction, impaired NO synthesis, and vasculogenic ED[4][18]

Male infertility and androgen profile​

  • Rastegar Panah 2024 (n = 303 infertile men) — serum B12 positively associated with total testosterone (ρ = 0.19; p = 0.001); highest B12 tertile had 56% lower odds of testosterone deficiency (adjusted OR 0.44; 95% CI 0.22–0.87)[3]
  • Banihani 2017 review — describes heterogeneous clinical/preclinical evidence concerning sperm count, motility and DNA damage, with proposed pathways including ↓ homocysteine toxicity, ↓ oxidative stress, ↓ NO-mediated damage, and anti-inflammatory effects[19]
  • Mathew 2026 — B12 deficiency drives oxidative stress that impairs gamete quality across sexes[20]
  • B12 deficiency is listed as an uncommon cause of infertility in the NEJM clinical-practice review[6]

Practical takeaway: investigate B12 when symptoms or nutritional/anatomic risk justify it, particularly after ileal resection or diversion. These associations do not establish B12 supplementation as an ED, testosterone or fertility treatment in B12-replete men.

Other Urologic Considerations​

Metabolic acidosis — the frequent co-traveler​

Ileal diversion-related B12 deficiency often coexists with hyperchloremic metabolic acidosis from ammonium-chloride reabsorption and bicarbonate wasting by bowel mucosa — chronic acidosis contributes to bone demineralization and compounds the nutritional burden.[1] See Urinary acidifiers & alkalinizers for oral bicarbonate dosing.

Bone health​

B12 deficiency is associated with osteoporosis in the general population; diversion patients already face bone loss from chronic metabolic acidosis — the combination makes both B12 surveillance and acid-base management important, not optional.[1]

Pediatric considerations​

  • Adequate B12 is important for childhood neurodevelopment; requirements are age-specific[13]
  • 28% of pediatric ileocystoplasty patients had low or low-normal B12 at mean follow-up of 83 mo[14]
  • Women of childbearing age who underwent childhood augmentation — combined B12 + folate deficiency (folate deficiency in 14.8% of pediatric reconstruction patients) increases neural-tube-defect risk in offspring; counsel accordingly[21]

Practical Clinical Summary​

ScenarioReview and action
Cystectomy with bowel diversionAnnual B12 measurement; investigate and replace deficiency according to cause and severity.[15]
Complete terminal ileal resectionAdult NICE guidance recommends lifelong IM replacement; distinguish this from partial ileal use.[23]
Pediatric augmentationLong-term nutritional surveillance with the pediatric team; use an age- and presentation-appropriate replacement regimen.[13][14]
Colonic reconstruction with preserved ileumDirect ileal loss is avoided, but this is not a blanket exemption from post-cystectomy surveillance or evaluation of other B12 risks.[10][15]
Sexual/fertility concernsTreat proven deficiency; current associations do not justify B12 as a stand-alone treatment in replete patients.[3][4][18][19]

See Also​

References​

1. Roth JD, Koch MO. "Metabolic and nutritional consequences of urinary diversion using intestinal segments to reconstruct the urinary tract." Urol Clin North Am. 2018;45(1):19–24. doi:10.1016/j.ucl.2017.09.007

2. Lenis AT, Lec PM, Chamie K, Mshs MD. "Bladder cancer: a review." JAMA. 2020;324(19):1980–1991. doi:10.1001/jama.2020.17598

3. Rastegar Panah M, Jarvi K, Lo K, El-Sohemy A. "Vitamin B12 is associated with higher serum testosterone concentrations and improved androgenic profiles among men with infertility." J Nutr. 2024;154(9):2680–2687. doi:10.1016/j.tjnut.2024.06.013

4. Xu J, Xu Z, Ge N, et al. "Association between folic acid, homocysteine, vitamin B12 and erectile dysfunction — a cross-sectional study." Andrologia. 2021;53(11):e14234. doi:10.1111/and.14234

5. Hashash JG, Elkins J, Lewis JD, Binion DG. "AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review." Gastroenterology. 2024;166(3):521–532. doi:10.1053/j.gastro.2023.11.303

6. Stabler SP. "Vitamin B12 deficiency." N Engl J Med. 2013;368(2):149–160. doi:10.1056/NEJMcp1113996

7. Steiner MS, Morton RA, Marshall FF. "Vitamin B12 deficiency in patients with ileocolic neobladders." J Urol. 1993;149(2):255–257. doi:10.1016/s0022-5347(17)36049-4

8. Pannek J, Haupt G, Schulze H, Senge T. "Influence of continent ileal urinary diversion on vitamin B12 absorption." J Urol. 1996;155(4):1206–1208.

9. Ganesan T, Khadra MH, Wallis J, Neal DE. "Vitamin B12 malabsorption following bladder reconstruction or diversion with bowel segments." ANZ J Surg. 2002;72(7):479–482. doi:10.1046/j.1445-2197.2002.02460.x

10. Fujisawa M, Gotoh A, Nakamura I, et al. "Long-term assessment of serum vitamin B12 concentrations in patients with various types of orthotopic intestinal neobladder." Urology. 2000;56(2):236–240. doi:10.1016/s0090-4295(00)00638-5

11. Sagalowsky AI, Frenkel EP. "Cobalamin profiles in patients after urinary diversion." J Urol. 2002;167(4):1696–1700.

12. Terai A, Okada Y, Shichiri Y, et al. "Vitamin B12 deficiency in patients with urinary intestinal diversion." Int J Urol. 1997;4(1):21–25. doi:10.1111/j.1442-2042.1997.tb00133.x

13. Rosenbaum DH, Cain MP, Kaefer M, et al. "Ileal enterocystoplasty and B12 deficiency in pediatric patients." J Urol. 2008;179(4):1544–1547. doi:10.1016/j.juro.2007.11.089

14. Vanderbrink BA, Cain MP, King S, et al. "Is oral vitamin B12 therapy effective for vitamin B12 deficiency in patients with prior ileocystoplasty?" J Urol. 2010;184(4 Suppl):1781–1785. doi:10.1016/j.juro.2010.05.049

15. European Association of Urology. Muscle-invasive and metastatic bladder cancer: follow-up. 2026. Guideline. Accessed September 12, 2026.

16. Langan RC, Goodbred AJ. "Vitamin B12 deficiency: recognition and management." Am Fam Physician. 2017;96(6):384–389.

17. Mauermann ML, Staff NP. "Peripheral neuropathy." JAMA. 2026;335(3):255–266. doi:10.1001/jama.2025.19400

18. Chen Y, Li J, Li T, et al. "Association between homocysteine, vitamin B12, folic acid and erectile dysfunction: a cross-sectional study in China." BMJ Open. 2019;9(5):e023003. doi:10.1136/bmjopen-2018-023003

19. Banihani SA. "Vitamin B12 and semen quality." Biomolecules. 2017;7(2):42. doi:10.3390/biom7020042

20. Mathew AR, Selita E, Regano C, et al. "Vitamin B12 and reproductive health: clinical insights, emerging mechanistic understanding, and nutritional aspects." Mol Reprod Dev. 2026;93(2):e70088. doi:10.1002/mrd.70088

21. Kalloo NB, Jeffs RD, Gearhart JP. "Long-term nutritional consequences of bowel segment use for lower urinary tract reconstruction in pediatric patients." Urology. 1997;50(6):967–971. doi:10.1016/S0090-4295(97)00470-6

22. AUA/SUFU. Adult neurogenic lower urinary tract dysfunction guideline, statement 58 and discussion. 2021. Guideline.

23. NICE. Vitamin B12 deficiency in over 16s: diagnosis and management (NG239). 2024, recommendations 1.3–1.6. Guideline. Accessed September 12, 2026.

24. Wang H, Li L, Qin LL, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018;3:CD004655. doi:10.1002/14651858.CD004655.pub3.

25. Sanz-Cuesta T, et al. "Oral versus intramuscular administration of vitamin B12 for vitamin B12 deficiency in primary care: a pragmatic, randomised, non-inferiority clinical trial (OB12)." BMJ Open. 2020;10:e033687. doi:10.1136/bmjopen-2019-033687.